Bare Financial Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25
Closed -$1.27K 1835
2025
Q4
$1.27K Sell
25
-117
-82% -$5.98K ﹤0.01% 1030
2025
Q3
$7.88K Buy
142
+22
+18% +$1.29K ﹤0.01% 318
2025
Q2
$8.28K Buy
120
+79
+193% +$5.37K ﹤0.01% 234
2025
Q1
$2.85K Buy
+41
New +$3.39K ﹤0.01% 180

Other funds holding NVO

Bare Financial Services's NVO Position: Q1 2026 in Review

Bare Financial Services sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 25 shares — an estimated $1.27K sold.

Bare Financial Services first reported a position in NVO in Q1 2025 and held it in 4 quarters. The position peaked at $8.28K in Q2 2025. 1,277 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Bare Financial Services reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Bare Financial Services sold 25 Novo Nordisk shares in Q1 2026, an estimated $1.27K.
  • Bare Financial Services first reported a position in Novo Nordisk in Q1 2025 and held it in 4 quarters.
  • Bare Financial Services's Novo Nordisk position peaked at $8.28K in Q2 2025.
  • 1,277 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Bare Financial Services's 13F filing for Q1 2026, filed 14 May 2026.